Home/ Stocks/ INVA

Innoviva, Inc. Common Stock

INVA XNAS

$22.89 +0.09 (+0.39%) ▲ 15-min delayed

Open

$22.72

High

$23.09

Low

$22.70

Volume

540.4K

Market Cap

$1.69B

About Innoviva, Inc. Common Stock

Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 159 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$97.99M	$186.59M	$2.52
FY 2025	$411.33M	$271.17M	$4.02
Q3 2025	$107.80M	$89.91M	$1.30
Q2 2025	$100.28M	$63.69M	$1.01

Earnings & Analyst Ratings

Next Earnings: Tue, Aug 4, 2026

Calendar →

Related Market News

No specific coverage for INVA yet. Check out our latest market news or earnings calendar.

Get INVA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Innoviva, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.